Meta-meta-analysis of the mortality risk associated with MRSA compared to MSSA bacteraemia
Infezioni in Medicina · 01.06.2024 · 32 (2)
DOI: 10.53854/liim-3202-2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Infezioni in Medicina, online erschienen am 01.06.2024. Verfasst von Shuaibu Suleiman Adeiza und 1 weiteren Autor:innen. Beteiligte Einrichtung: Dept of Pharmaceutical Microbiology & Biotechnology, Faculty of Pharmaceutical Sciences, Ahmadu Bello University, Zaria, Nigeria. Die Arbeit wurde bisher 13-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Staphylococcus aureus bacteraemia (SAB) is a bloodstream infection that carries a high risk of exacerbating a diseased state and may result in an increased death rate. The aim of this study was to assess mortality risk in Methicillin Resistant Staphylococcus aureus (MRSA) bacteraemia compared to Methicillin Susceptible Staphylococcus aureus (MSSA) bacteraemia through meta-meta-analyses. The study followed PRISMA guidelines, conducting a comprehensive search in Scopus, PubMed, and Google Scholar. It included full-text systematic reviews and meta-analyses comparing MRSA vs. MSSA bacteraemia, excluding reviews without data pooling and unclear selection criteria. Validity was assessed using QUOROM and AMSTAR. Edwards' Venn diagrams were used to visualized overlaps between primary studies. Aggregated odds ratio (OR) and risk ratios with 95% confidence intervals were calculated using the random-effect model. Heterogeneity was evaluated using the Higgins I2 statistic. The study included 3 meta-analysis studies, a total of 38,159 patients, with 9,056 having MRSA bacteraemia and 29,103 having MSSA bacteraemia. Data were collected from 46 different outcome studies published between 2001 and 2022. The meta-analyses used 7 to 33 primary studies from 1990 to 2020, with no overlap. Odds ratios (ORs) ranged from 1.78 to 2.92, while relative risks (RR) ranged from 1.57 to 2.37 for the included meta-anlysis. The pooled analysis confirmed a higher risk of mortality in patients with MRSA bacteraemia (OR: 2.35, RR: 2.01, HR: 1.61) compared to MSSA bacteraemia. Heterogeneity among the studies was considerable (I2: 90-91%). The study strongly supports that most patient deaths from SAB are linked to MRSA rather than MSSA. This highlights the significant public health problem posed by SAB, with difficult and often unsuccessful treatment leading to increased mortality and high healthcare costs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dept of Pharmaceutical Microbiology & Biotechnology, Faculty of Pharmaceutical Sciences, Ahmadu Bello University, Zaria, Nigeria.
- Dept of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences, Usmanu Dafodiyo University Sokoto, Nigeria.
- Advanced Molecular Laboratory, Department of Microbiology, President Abdul Hamid Medical College, Karimganj, Kishoreganj-2310, Bangladesh.
- COVID-19 Diagnostic Laboratory, Department of Microbiology, Noakhali Science and Technology University, Noakhali, Bangladesh.
Zitieren
APA
Adeiza, S. S., & Aminul, I. (2024). Meta-meta-analysis of the mortality risk associated with MRSA compared to MSSA bacteraemia. Infezioni in Medicina, 32(2). https://doi.org/10.53854/liim-3202-2
Vancouver
Adeiza SS, Aminul I. Meta-meta-analysis of the mortality risk associated with MRSA compared to MSSA bacteraemia. Infezioni in Medicina. 2024;32(2). doi:10.53854/liim-3202-2
BibTeX
@article{Adeiza2024,
author = {Adeiza, Shuaibu Suleiman and Aminul, Islam},
title = {Meta-meta-analysis of the mortality risk associated with MRSA compared to MSSA bacteraemia},
journal = {Infezioni in Medicina},
year = {2024},
volume = {32},
number = {2},
doi = {10.53854/liim-3202-2}
}
EUVIMED